<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0517-2020-25
</NDCCode>
<PackageDescription>
25 VIAL, SINGLE-DOSE in 1 TRAY (0517-2020-25) > 20 mL in 1 VIAL, SINGLE-DOSE
</PackageDescription>
<NDC11Code>
00517-2020-25
</NDC11Code>
<ProductNDC>
0517-2020
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Nutrilyte Ii
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Multi-electrolyte
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION, CONCENTRATE
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
19901001
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
American Regent, Inc.
</LabelerName>
<SubstanceName>
POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM ACETATE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE
</SubstanceName>
<StrengthNumber>
98; 74.5; 64.6; 25.5; 16.55
</StrengthNumber>
<StrengthUnit>
mg/mL; mg/mL; mg/mL; mg/mL; mg/mL
</StrengthUnit>
<Pharm_Classes>
Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2017-07-27
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>